Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
603387.SS
STRONG BUYREMOVEGetein Biotech, Inc · Healthcare · China · $668M · Avg Vol: $12M/d
Getein Biotech manufactures in vitro diagnostic (IVD) products. The post-pandemic IVD market in China is highly competitive with severe pricing pressure from government volume-based procurement, offering poor risk-reward.
COMPANY DESCRIPTION
Getein Biotech is a leading developer and manufacturer of In Vitro Diagnostic (IVD) instruments and reagents, specializing in Point-of-Care Testing (POCT) for cardiovascular, inflammatory, and kidney diseases. The company maintains a strong market position in China's rapid diagnostic sector through its proprietary technology platforms and extensive distribution network across domestic hospitals. It is a highly innovative player expanding its global footprint in automated laboratory systems.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 269M | 202M | 172M | 155M | -16.7% |
| EPS | 0.14 | 0.08 | 0.07 | 0.07 | -23.4% |
| Shares | 507M | 507M | 507M | 507M | 0.0% |
| Debt | 87M | 99M | 86M | 71M | -6.6% |
| Equity | 367M | 378M | 387M | 407M | 3.5% |
| Op CF | 71M | 49M | 63M | 58M | -6.7% |
| Inv CF | -112M | -53M | -51M | -32M | — |
| Fin CF | -7M | -22M | -32M | -31M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 603387.SS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 603387.SS | Getein Biotech, Inc(you) | $668M | 90 | STRONG BUY |
| 1763.HK | China Isotope & Radiation Corporation | $734M | 85 | STRONG BUY |
| 1858.HK | Beijing Chunlizhengda Medical Instruments Co., Ltd. | $462M | 90 | STRONG BUY |
| 1789.HK | AK Medical Holdings Limited | $828M | 95 | STRONG BUY |
| 1302.HK | LifeTech Scientific Corporation | $932M | 84 | STRONG BUY |
| 2190.HK | Zylox-Tonbridge Medical Technology Co., Ltd. | $853M | 82 | STRONG BUY |
| 300206.SZ | Edan Instruments, Inc. | $1.2B | 94 | STRONG BUY |
| 688581.SS | Hangzhou AGS MedTech Co., Ltd. | $671M | 73 | BUY |
| 2172.HK | MicroPort NeuroScientific Corporation | $675M | 73 | BUY |
| 600587.SS | Shinva Medical Instrument Co.,Ltd. | $1.2B | 84 | STRONG BUY |
Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%